Waste Management, Inc. (WM)

Theseus Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	23,950	22,063	20,426	19,698	17,931	15,218
Revenue Growth (YoY)	14.18%	8.01%	3.70%	9.85%	17.83%	-1.53%
Cost of Revenue	14,438	13,383	12,606	12,294	11,111	9,341
Gross Profit	9,512	8,680	7,820	7,404	6,820	5,877
Selling, General & Admin	2,495	2,104	1,926	1,938	1,864	1,728
Operating Expenses	5,069	4,371	3,997	3,976	3,863	3,399
Operating Income	4,443	4,309	3,823	3,428	2,957	2,478
Interest Expense	-796	-598	-500	-378	-365	-425
Earnings From Equity Investments	8	4	-60	-67	-36	-68
Other Non Operating Income (Expenses)	4	-4	6	-2	5	5
EBT Excluding Unusual Items	3,659	3,711	3,269	2,981	2,561	1,990
Merger & Restructuring Charges	-189	-164	-5	-1	-8	-9
Impairment of Goodwill	-16	-	-168	-	-	-
Gain (Loss) on Sale of Investments	-	-	-107	-	-	-
Gain (Loss) on Sale of Assets	18	26	-	5	44	33
Asset Writedown	-90	-90	-	-50	-8	-68
Other Unusual Items	29	-25	32	-17	-240	-53
Pretax Income	3,411	3,458	3,021	2,918	2,349	1,893
Income Tax Expense	689	713	745	678	532	397
Earnings From Continuing Operations	2,722	2,745	2,276	2,240	1,817	1,496
Minority Interest in Earnings	-1	1	28	-2	-1	-
Net Income	2,721	2,746	2,304	2,238	1,816	1,496
Net Income to Common	2,721	2,746	2,304	2,238	1,816	1,496
Net Income Growth	6.96%	19.18%	2.95%	23.24%	21.39%	-10.42%
Shares Outstanding (Basic)	402	402	405	413	420	423
Shares Outstanding (Diluted)	404	403	407	415	423	425
Shares Change (YoY)	-0.06%	-0.86%	-1.95%	-1.87%	-0.52%	-0.56%
EPS (Basic)	6.77	6.84	5.69	5.42	4.32	3.54
EPS (Diluted)	6.74	6.81	5.66	5.39	4.29	3.52
EPS Growth	7.17%	20.32%	5.01%	25.64%	21.88%	-9.97%
Free Cash Flow	2,163	2,159	1,824	1,949	2,434	1,771
Free Cash Flow Per Share	5.36	5.35	4.48	4.70	5.75	4.17
Dividend Per Share	3.150	3.000	2.800	2.600	2.300	2.180
Dividend Growth	8.62%	7.14%	7.69%	13.04%	5.50%	6.34%
Gross Margin	39.72%	39.34%	38.29%	37.59%	38.04%	38.62%
Operating Margin	18.55%	19.53%	18.72%	17.40%	16.49%	16.28%
Profit Margin	11.36%	12.45%	11.28%	11.36%	10.13%	9.83%
Free Cash Flow Margin	9.03%	9.79%	8.93%	9.89%	13.57%	11.64%
EBITDA	7,017	6,576	5,894	5,466	4,956	4,149
EBITDA Margin	29.30%	29.80%	28.85%	27.75%	27.64%	27.26%
D&A For EBITDA	2,574	2,267	2,071	2,038	1,999	1,671
EBIT	4,443	4,309	3,823	3,428	2,957	2,478
EBIT Margin	18.55%	19.53%	18.72%	17.40%	16.49%	16.28%
Effective Tax Rate	20.20%	20.62%	24.66%	23.23%	22.65%	20.97%

Updated Jul 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q